"Elekta has gained an experienced development team with mature, easy-to-use, stable clinical products. And the established sales and marketing infrastructure of Elekta is the perfect foundation to further introduce this valuable technology to the radiation oncology market. Beyond just today however, the really exciting things are yet ahead as we start to integrate RMI:s solutions with MOSAIQ and in the future with our state-of-the art linear accelerators", says Elekta's President and CEO Tomas Puusepp.

RMI was founded in 2000 based on research from McGill University, Montreal. The CEO of the company, Tony Falco, Ph.D. is one of the founders and has over 15 years experience in advanced imaging technology; clinical, product development, supply, and IP creation. The company has 35 employees, of whom most are based in Montreal, Canada.

Tony Falco, CEO of RMI, says: "These are exciting times. RMI provides solutions compatible with all vendors' simulators and linear accelerators and together with Elekta's world-wide customer network it provides us for the first time with the ability to improve clinical standards on a global basis. In addition, being fully integrated with a leading clinical solutions provider like Elekta makes it possible for us to deliver truly unique integrated clinical solutions in the future, all of which is important in improving patient care."

Elekta expects to consolidate RMI into its accounts as from June 1st, 2010. The revenue for 2010/11 is expected to be around CAD 10 M. The transaction is forecasted to have a minor dilutive effect on reported earnings per share during fiscal year 10/11 and be mildly accretive the following fiscal year.

SOURCE Elekta